Understanding epigenetics - The potential rationale for BET inhibition in management of cardiovascular disease.
25 August 2018 (00:00 - 00:00)
Organised by:
About the speaker
Brigham and Women's Hospital, Boston (United States of America)
4 More presentations in this session
Professor E. Stroes (Amsterdam, NL)
A clinical view on BET inhibition in targeting residual risk in cardiovascular disease and diabetes.
Professor K. Ray (London, GB)
Access the full session
The Event
ESC Congress 2018
25 August - 29 August 2018
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
